Kister, Ilya

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

MRI characteristics of neuromyelitis optica spectrum disorder: An international update

Kim, H. J., Paul, F., Lana-Peixoto, M. A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E. C., Sato, D. K., de Seze, J., Wuerfel, J., et al. (2015) · Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 664

Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica

Kister, I., Herbert, J., Zhou, Y., & Ge, Y. (2013) · Multiple Sclerosis International

Multiple Sclerosis Research StudiesCerebral Venous Sinus Thrombosis

Cited by 75

Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?

Kister, I., & Paul, F. (2015) · Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 13

A longitudinal study of symptom botheration in multiple sclerosis

Kister, I., Bacon, T., & Cutter, G. R. (2020) · Multiple Sclerosis and Related Disorders

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 12